Your browser doesn't support javascript.
loading
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
Cheon, Jaekyung; Yoo, Changhoon; Hong, Jung Yong; Kim, Han Sang; Lee, Dae-Won; Lee, Myung Ah; Kim, Jin Won; Kim, Ilhwan; Oh, Sang-Bo; Hwang, Jun-Eul; Chon, Hong Jae; Lim, Ho Yeong.
Afiliación
  • Cheon J; Department of Hematology-Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
  • Yoo C; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
  • Hong JY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim HS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lee DW; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Brain Korea 21 FOUR Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee MA; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim JW; Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, Catholic Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Kim I; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Oh SB; Department of Oncology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.
  • Hwang JE; Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do, South Korea.
  • Chon HJ; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, South Korea.
  • Lim HY; Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
Liver Int ; 42(3): 674-681, 2022 03.
Article en En | MEDLINE | ID: mdl-34792284
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Liver Int Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Liver Int Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur